Pure Global

Liquichek Whole Blood Immunosuppressant Control - Taiwan Registration 90ccb2c4d151731ee5510278b9784f4e

Access comprehensive regulatory information for Liquichek Whole Blood Immunosuppressant Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 90ccb2c4d151731ee5510278b9784f4e and manufactured by BIO-RAD LABORATORIES. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
90ccb2c4d151731ee5510278b9784f4e
Registration Details
Taiwan FDA Registration: 90ccb2c4d151731ee5510278b9784f4e
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Liquichek Whole Blood Immunosuppressant Control
TW: ็ซ‹ๅฏๆธฌ ๅ…จ่ก€ๅ…็–ซๆŠ‘ๅˆถๅ“็ฎกๆถฒ
Risk Class 2
MD

Registration Details

90ccb2c4d151731ee5510278b9784f4e

Ministry of Health Medical Device Import No. 025270

DHA05602527006

Company Information

United States

Product Details

This product is an analysed controlled substance intended to monitor the precision of laboratory testing procedures for analytes in the table: Cyclosporine, Everolimus, Sirolimus, Tacrolimus.

A Clinical chemistry and clinical toxicology

A1660 Quality Control Materials (Analytical and Non-Analytical)

Imported from abroad

Dates and Status

Aug 26, 2013

Aug 26, 2028